Literature DB >> 14997339

Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction.

S I Lee1, H S Jeon, W H Yoo.   

Abstract

Dementia is a very rare neurological manifestation of systemic lupus erythematosus (SLE) and has a deep link with antiphospholipid antibodies (APL) and cerebral infarction in its development. However, nonvascular dementia irrelevant to APL or cerebral infarction has not been reported in patients with SLE until now. We describe a case of reversible dementia in an SLE patient without APL or cerebral infarction which was successfully treated with corticosteroid and cyclophosphamide. There are two significant points in this case. One is that humoral factors other than APL might be involved in the development of dementia. Secondly, reversible dementia without APL or cerebral infarction may respond more favorably to immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997339     DOI: 10.1007/s00296-003-0405-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

Review 1.  Antiphospholipid antibodies and thrombosis.

Authors:  M Greaves
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

2.  Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations.

Authors:  N S Lai; J L Lan
Journal:  Lupus       Date:  2000       Impact factor: 2.911

3.  Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.

Authors:  C C Mok; C S Lau; R W Wong
Journal:  J Rheumatol       Date:  2001-04       Impact factor: 4.666

4.  Multi-infarct dementia. A cause of mental deterioration in the elderly.

Authors:  V C Hachinski; N A Lassen; J Marshall
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

5.  Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

Authors:  R A Asherson; D Mercey; G Phillips; N Sheehan; A E Gharavi; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

Review 6.  Lupus and the central nervous system.

Authors:  S G West
Journal:  Curr Opin Rheumatol       Date:  1996-09       Impact factor: 5.006

7.  Reversible dementia and chorea in a young woman with the lupus anticoagulant.

Authors:  G Van Horn; F C Arnett; M M Dimachkie
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

8.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

Review 9.  Dilemmas in neuropsychiatric lupus.

Authors:  J A Kovacs; M B Urowitz; D D Gladman
Journal:  Rheum Dis Clin North Am       Date:  1993-11       Impact factor: 2.670

10.  Neuropsychiatric Systemic Lupus Erythematosus.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.972

View more
  1 in total

1.  Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive Therapy.

Authors:  Yuya Fujita; Shoichi Fukui; Midori Ishida; Yushiro Endo; Sosuke Tsuji; Ayuko Takatani; Takashi Igawa; Toshimasa Shimizu; Masataka Umeda; Remi Sumiyoshi; Ayako Nishino; Tomohiro Koga; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Atsushi Kawakami
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.